Fujifilm/MediVector Antiviral Favipiravir May Protect Against Ebola

The antivirval favipiravir (T-705), which is being developed by Fujifilm and its US subsidiary MediVector, may provide post-exposure prophylaxis (PEP) protection against Ebola, researchers reported in the British medical journal The Lancet Infectious Diseases.